Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity.
Sung CYW, Hayase N, Yuen PST, Lee J, Fernandez K, Hu X, Cheng H, Star RA, Warchol ME, Cunningham LL.
Sci Adv. 2024 Jul 26;10(30):eadk9878. doi: 10.1126/sciadv.adk9878. Epub 2024 Jul 24.
Canine deafness.
Strain GM.
Vet Clin North Am Small Anim Pract. 2012 Nov;42(6):1209-24. doi: 10.1016/j.cvsm.2012.08.010. Epub 2012 Oct 10.
Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
Tan WJT, Vlajkovic SM.
Int J Mol Sci. 2023 Nov 20;24(22):16545. doi: 10.3390/ijms242216545.
The genetics of deafness.
Nance WE.
Ment Retard Dev Disabil Res Rev. 2003;9(2):109-19. doi: 10.1002/mrdd.10067.
Mitochondrial deafness.
Kokotas H, Petersen MB, Willems PJ.
Clin Genet. 2007 May;71(5):379-91. doi: 10.1111/j.1399-0004.2007.00800.x.
miR-182 prevented ototoxic deafness induced by co-administration of kanamycin and furosemide in rats.
Chen J, Liu Z, Yan H, Xing W, Mi W, Wang R, Li W, Chen F, Qiu J, Zha D.
Neurosci Lett. 2020 Apr 1;723:134861. doi: 10.1016/j.neulet.2020.134861. Epub 2020 Feb 24.
Deafness caused by ototoxic drugs.
LAFF HI.
Rocky Mt Med J. 1960 Jun;57:48-50.
BRAF inhibition protects against hearing loss in mice.
Ingersoll MA, Malloy EA, Caster LE, Holland EM, Xu Z, Zallocchi M, Currier D, Liu H, He DZZ, Min J, Chen T, Zuo J, Teitz T.
Sci Adv. 2020 Dec 2;6(49):eabd0561. doi: 10.1126/sciadv.abd0561. Print 2020 Dec.
Drug-induced hearing loss.
[No authors listed]
Prescrire Int. 2014 Dec;23(155):290-4.
[Ototoxicity of drugs].
Fossati C.
Clin Ter. 1986 Jul 31;118(2):137-43.
